HSPG2 and neoplasm: In cirrhotic patients, multiple signaling pathways and gene expressions can be affected by upgrading the microRNA-21 level and downgrading the microRNA-122, microRNA-29, microRNA-223, and microRNA-193 levels, thereby decreasing cell apoptosis and increasing tumor cell proliferation, invasion, and migration, eventually promoting the development of PLC (21).